1. Investigating the impact of telomere dysfunction on the cancer genome. (July 2016) Authors: Escudero, L.; Fegan, C.; Pepper, C.; Ashelford, K.; Norris, K.; Cleal, K.; Liddiard, K.; Baird, D.M. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PRELIMINARY RESULTS OF A PHASE 1B STUDY OF TIRABRUTINIB (GS‐4059/ONO‐4059) IN COMBINATION WITH ENTOSPLETINIB IN PATIENTS WITH B‐CELL MALIGNANCIES. (June 2017) Authors: Morschhauser, F.; Danilov, A.V.; Hodson, D.J.; Salles, G.A.; Starodub, A.; Mitra, S.; Yang, Y.; Walter, H.; Fegan, C. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 266 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. User attitudes towards virtual home assessment technologies. (18th August 2022) Authors: Lanfranchi, V.; Jones, N.; Read, J.; Fegan, C.; Field, B.; Simpson, E.; Revitt, C.; Cudd, P.; Ciravegna, F. Journal: Journal of medical engineering & technology Issue: Volume 46:Number 6(2022) Page Start: 536 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗